CLGN News and Press, CollPlant Holdings Ltd. From 01/02/24

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants PR Newswire The current market for breast implants is estimated at $2.6 billion a year CollPlant expects the study to conclude by the first half of 2024 CollPlant ...

2023-11-29 14:21:06 ET CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Conference Call November 29, 2023 10:00 AM ET Company Participants Dory Kurowski - Investor Relations Yehiel Tal - Chief Executive Officer Eran Rotem - Deputy Chief Executive Officer an...

2023-11-29 09:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-29 07:06:05 ET More on CollPlant Biotechnologies CollPlant says patent granted in U.S. for photocurable dermal filler Seeking Alpha’s Quant Rating on CollPlant Biotechnologies Historical earnings data for CollPlant Biotechnologies Financial inf...

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023 PR Newswire Received a $10 million milestone payment in the third quarter from partner, AbbVie Inc., for achieving a major milestone in the second quarter in accordance with the strategic collabor...

Addex Therapeutics Ltd (ADXN) is expected to report $-4 for Q3 2023 Eco Wave Power Global AB (publ) (WAVE) is expected to report for quarter end 2023-09-30 AmeraMex International, Inc. (AMMX) is expected to report for Q3 2023 iClick Interactive Asia Group Limited (ICLK) is expected to...

CollPlant Biotechnologies Ltd. (CLGN) is expected to report $-0.02 for Q3 2023

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire -  Conference call to be held on Wednesday, November 29, 2023 at 10:00 a.m. U.S. EDT - REHOVOT, Israel , Nov. 9, 2023 /P...

2023-11-01 08:00:47 ET More on CollPlant Biotechnologies Seeking Alpha’s Quant Rating on CollPlant Biotechnologies Historical earnings data for CollPlant Biotechnologies Financial information for CollPlant Biotechnologies For further details see: C...

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler PR Newswire - Intellectual Property Rights Secured in One of the Largest Target Markets for CollPlant's Potential Products - REHOVOT, Israel , Nov. 1, 2023 /PRNe...